Dr. Okon holds a degree in biochemistry and a postgraduate MSc degree in medical biotechnology from the University of Westminster, London. He pursued his doctoral studies in clinical medical research with a focus on ovarian cancer at Hammersmith Hospital campus of Imperial College London. Upon graduation, he undertook postdoctoral training at the University of Oklahoma Health Sciences Center (OUHSC), where he spent five years working on biomedical and clinical research projects in the areas of cancer, diabetes, cardiovascular and metabolic dysfunction. Additionally, Dr. Okon has earned Project Management Professional (PMP) certification, and is currently an MPH candidate.
Dr. Okon's research focus is the molecular mechanisms that instigate the pathogenesis and/or accentuation of cardiometabolic disorders, including cancer, obesity and diabetes. In particular, he studies mechanisms associated with angiogenesis in the context of diabetic wound-healing, obesity or cancer, which has involved untangling the complex interplay between transmembrane receptor signaling, trafficking and regulation of proangiogenic factors. His work aims to integrate population-based public health problems with evidence-driven molecular research in order to create novel and innovative solutions.